Diagnostic Nuclear Medicines Market Report

Europe Diagnostic Nuclear Medicines Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 15, 2020
  • PAGES：200
  • REPORT CODE：GMM436900
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Diagnostic Nuclear Medicines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Diagnostic Nuclear Medicines Market Segmentations:

    By Player:

    • Bayer

    • Jubilant Pharma

    • GE Healthcare

    • Bracco Imaging

    • Curium Pharmaceuticals

    • China Isotope & Radiation

    • SIEMENS

    • Navidea

    • Triad Isotopes

    • Dongcheng

    • Novartis

    • Nordion

    • Eli Lilly

    • Lantheus

    By Type:

    • Tc-99m

    • F-18

    • Other

    By End-User:

    • Oncology

    • Cardiology

    • Other

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Diagnostic Nuclear Medicines Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of Tc-99m from 2014 to 2026

    • 1.3.2 Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of F-18 from 2014 to 2026

    • 1.3.3 Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.2 Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of Cardiology from 2014 to 2026

    • 1.4.3 Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Diagnostic Nuclear Medicines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Diagnostic Nuclear Medicines by Major Types

      • 3.4.1 Market Size and Growth Rate of Tc-99m

      • 3.4.2 Market Size and Growth Rate of F-18

      • 3.4.3 Market Size and Growth Rate of Other

    4 Segmentation of Diagnostic Nuclear Medicines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Diagnostic Nuclear Medicines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Diagnostic Nuclear Medicines for Oncology

      • 4.4.2 Market Size and Growth Rate of Diagnostic Nuclear Medicines for Cardiology

      • 4.4.3 Market Size and Growth Rate of Diagnostic Nuclear Medicines for Other

    5 Market Analysis by Major Regions

    • 5.1 Europe Diagnostic Nuclear Medicines Production Analysis by Top Regions

    • 5.2 Europe Diagnostic Nuclear Medicines Consumption Analysis by Top Regions

    • 5.3 Europe Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.3 France Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Diagnostic Nuclear Medicines Market among Top Countries

    • 6.1 Top 5 Export Countries in Diagnostic Nuclear Medicines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Diagnostic Nuclear Medicines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Diagnostic Nuclear Medicines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Diagnostic Nuclear Medicines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Diagnostic Nuclear Medicines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Diagnostic Nuclear Medicines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Diagnostic Nuclear Medicines Landscape Analysis

    • 7.1 Germany Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 7.2 Germany Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    8. UK Diagnostic Nuclear Medicines Landscape Analysis

    • 8.1 UK Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 8.2 UK Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    9. France Diagnostic Nuclear Medicines Landscape Analysis

    • 9.1 France Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 9.2 France Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    10. Italy Diagnostic Nuclear Medicines Landscape Analysis

    • 10.1 Italy Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 10.2 Italy Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    11. Spain Diagnostic Nuclear Medicines Landscape Analysis

    • 11.1 Spain Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 11.2 Spain Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    12. Poland Diagnostic Nuclear Medicines Landscape Analysis

    • 12.1 Poland Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 12.2 Poland Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    13. Russia Diagnostic Nuclear Medicines Landscape Analysis

    • 13.1 Russia Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 13.2 Russia Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    14. Switzerland Diagnostic Nuclear Medicines Landscape Analysis

    • 14.1 Switzerland Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 14.2 Switzerland Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    15. Turkey Diagnostic Nuclear Medicines Landscape Analysis

    • 15.1 Turkey Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 15.2 Turkey Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Landscape Analysis by Top Countries

      • 16.3.1 Denmark Diagnostic Nuclear Medicines Market Volume and Growth Rate

      • 16.3.2 Finland Diagnostic Nuclear Medicines Market Volume and Growth Rate

      • 16.3.3 Norway Diagnostic Nuclear Medicines Market Volume and Growth Rate

      • 16.3.4 Sweden Diagnostic Nuclear Medicines Market Volume and Growth Rate

      • 16.3.6 Iceland Diagnostic Nuclear Medicines Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Landscape Analysis by Top Countries

      • 17.3.1 Belgium Diagnostic Nuclear Medicines Market Volume and Growth Rate

      • 17.3.2 Netherlands Diagnostic Nuclear Medicines Market Volume and Growth Rate

      • 17.3.3 Luxembourg Diagnostic Nuclear Medicines Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Landscape Analysis by Top Countries

      • 18.3.1 Estonia Diagnostic Nuclear Medicines Market Volume and Growth Rate

      • 18.3.2 Latvia Diagnostic Nuclear Medicines Market Volume and Growth Rate

      • 18.3.3 Lithuania Diagnostic Nuclear Medicines Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Bayer

      • 19.1.1 Bayer Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Jubilant Pharma

      • 19.2.1 Jubilant Pharma Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 GE Healthcare

      • 19.3.1 GE Healthcare Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Bracco Imaging

      • 19.4.1 Bracco Imaging Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Curium Pharmaceuticals

      • 19.5.1 Curium Pharmaceuticals Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 China Isotope & Radiation

      • 19.6.1 China Isotope & Radiation Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 SIEMENS

      • 19.7.1 SIEMENS Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Navidea

      • 19.8.1 Navidea Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Triad Isotopes

      • 19.9.1 Triad Isotopes Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Dongcheng

      • 19.10.1 Dongcheng Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Novartis

      • 19.11.1 Novartis Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Nordion

      • 19.12.1 Nordion Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Eli Lilly

      • 19.13.1 Eli Lilly Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Lantheus

      • 19.14.1 Lantheus Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    The List of Tables and Figures (Totals 107 Figures and 138 Tables)

    • Figure Product Picture

    • Figure Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of Tc-99m from 2014 to 2026

    • Figure Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of F-18 from 2014 to 2026

    • Figure Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Europe Diagnostic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Germany Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure France Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Diagnostic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Diagnostic Nuclear Medicines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Diagnostic Nuclear Medicines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Diagnostic Nuclear Medicines by Different Types from 2014 to 2026

    • Table Consumption Share of Diagnostic Nuclear Medicines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Tc-99m

    • Figure Market Size and Growth Rate of F-18

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Diagnostic Nuclear Medicines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Diagnostic Nuclear Medicines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Other

    • Table Europe Diagnostic Nuclear Medicines Production by Major Regions

    • Table Europe Diagnostic Nuclear Medicines Production Share by Major Regions

    • Figure Europe Diagnostic Nuclear Medicines Production Share by Major Countries and Regions in 2014

    • Table Europe Diagnostic Nuclear Medicines Consumption by Major Regions

    • Table Europe Diagnostic Nuclear Medicines Consumption Share by Major Regions

    • Table Germany Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table UK Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table France Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Italy Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Spain Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Poland Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Russia Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Switzerland Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Turkey Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Diagnostic Nuclear Medicines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Diagnostic Nuclear Medicines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Diagnostic Nuclear Medicines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Diagnostic Nuclear Medicines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Germany Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table Germany Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Germany Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table UK Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table UK Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table UK Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table UK Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table France Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table France Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table France Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table France Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table Italy Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Italy Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table Italy Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Italy Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table Spain Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Spain Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table Spain Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Spain Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table Poland Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Poland Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table Poland Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Poland Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table Russia Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Russia Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table Russia Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Russia Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Switzerland Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table Switzerland Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Switzerland Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Turkey Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table Turkey Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Turkey Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Diagnostic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Diagnostic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Diagnostic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Diagnostic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Company Profile and Development Status of Curium Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curium Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Curium Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Curium Pharmaceuticals

    • Table Product and Service Introduction of Curium Pharmaceuticals

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

    • Table Company Profile and Development Status of SIEMENS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS

    • Figure Sales and Growth Rate Analysis of SIEMENS

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Product and Service Introduction of SIEMENS

    • Table Company Profile and Development Status of Navidea

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea

    • Figure Sales and Growth Rate Analysis of Navidea

    • Figure Revenue and Market Share Analysis of Navidea

    • Table Product and Service Introduction of Navidea

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US